OBJECTIVE: To review the current trends in optical imaging to guide oncologic surgery. BACKGROUND: Surgical resection remains the cornerstone of therapy for patients with early stage solid malignancies and more than half of all patients with cancer undergo surgery each year. The technical ability of the surgeon to obtain clear surgical margins at the initial resection remains crucial to improve overall survival and long-term morbidity. Current resection techniques are largely based on subjective and subtle changes associated with tissue distortion by invasive cancer. As a result, positive surgical margins occur in a significant portion of tumor resections, which is directly correlated with a poor outcome. METHODS: A comprehensive review of studies evaluating optical imaging techniques is performed. RESULTS: A variety of cancer imaging techniques have been adapted or developed for intraoperative surgical guidance that have been shown to improve functional and oncologic outcomes in randomized clinical trials. There are also a large number of novel, cancer-specific contrast agents that are in early stage clinical trials and preclinical development that demonstrate significant promise to improve real-time detection of subclinical cancer in the operative setting. CONCLUSIONS: There has been an explosion of intraoperative imaging techniques that will become more widespread in the next decade.
OBJECTIVE: To review the current trends in optical imaging to guide oncologic surgery. BACKGROUND: Surgical resection remains the cornerstone of therapy for patients with early stage solid malignancies and more than half of all patients with cancer undergo surgery each year. The technical ability of the surgeon to obtain clear surgical margins at the initial resection remains crucial to improve overall survival and long-term morbidity. Current resection techniques are largely based on subjective and subtle changes associated with tissue distortion by invasive cancer. As a result, positive surgical margins occur in a significant portion of tumor resections, which is directly correlated with a poor outcome. METHODS: A comprehensive review of studies evaluating optical imaging techniques is performed. RESULTS: A variety of cancer imaging techniques have been adapted or developed for intraoperative surgical guidance that have been shown to improve functional and oncologic outcomes in randomized clinical trials. There are also a large number of novel, cancer-specific contrast agents that are in early stage clinical trials and preclinical development that demonstrate significant promise to improve real-time detection of subclinical cancer in the operative setting. CONCLUSIONS: There has been an explosion of intraoperative imaging techniques that will become more widespread in the next decade.
Authors: Kristine E Day; Lauren N Beck; C Hope Heath; Conway C Huang; Kurt R Zinn; Eben L Rosenthal Journal: Cancer Biol Ther Date: 2013-01-08 Impact factor: 4.742
Authors: Catherine F Poh; J Scott Durham; Penelope M Brasher; Donald W Anderson; Kenneth W Berean; Calum E MacAulay; J Jack Lee; Miriam P Rosin Journal: BMC Cancer Date: 2011-10-25 Impact factor: 4.430
Authors: Kiranya E Tipirneni; Jason M Warram; Lindsay S Moore; Andrew C Prince; Esther de Boer; Aditi H Jani; Irene L Wapnir; Joseph C Liao; Michael Bouvet; Nicole K Behnke; Mary T Hawn; George A Poultsides; Alexander L Vahrmeijer; William R Carroll; Kurt R Zinn; Eben Rosenthal Journal: Ann Surg Date: 2017-07 Impact factor: 12.969
Authors: K E Tipirneni; E L Rosenthal; L S Moore; A D Haskins; N Udayakumar; A H Jani; W R Carroll; A B Morlandt; M Bogyo; J Rao; Jason M Warram Journal: Mol Imaging Biol Date: 2017-10 Impact factor: 3.488
Authors: Jianfeng Wang; Yang Xu; Kelly J Mesa; Fredrick A South; Eric J Chaney; Darold R Spillman; Ronit Barkalifa; Marina Marjanovic; P Scott Carney; Anna M Higham; Z George Liu; Stephen A Boppart Journal: Biomed Opt Express Date: 2018-11-28 Impact factor: 3.732
Authors: Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert Journal: Nat Rev Clin Oncol Date: 2017-01-17 Impact factor: 66.675
Authors: Lindsay S Moore; Eben L Rosenthal; Thomas K Chung; Esther de Boer; Neel Patel; Andrew C Prince; Melissa L Korb; Erika M Walsh; E Scott Young; Todd M Stevens; Kirk P Withrow; Anthony B Morlandt; Joshua S Richman; William R Carroll; Kurt R Zinn; Jason M Warram Journal: J Nucl Med Date: 2016-09-01 Impact factor: 10.057